ProKidney Corp.
PROK
$3.02
-$0.28-8.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 527.00K | 306.00K | 76.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 527.00K | 306.00K | 76.00K | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 527.00K | 306.00K | 76.00K | -- | -- |
| SG&A Expenses | 52.67M | 52.27M | 50.76M | 40.58M | 42.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 176.84M | 179.97M | 178.43M | 150.99M | 153.96M |
| Operating Income | -176.32M | -179.66M | -178.35M | -150.99M | -153.96M |
| Income Before Tax | -163.65M | -166.06M | -163.93M | -136.09M | -133.77M |
| Income Tax Expenses | 799.00K | -105.00K | -598.00K | 491.00K | 3.75M |
| Earnings from Continuing Operations | -164.45 | -165.95 | -163.34 | -136.58 | -137.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 91.98M | 97.53M | 102.15M | 90.97M | 98.83M |
| Net Income | -72.47M | -68.43M | -61.19M | -45.61M | -38.68M |
| EBIT | -176.32M | -179.66M | -178.35M | -150.99M | -153.96M |
| EBITDA | -170.19M | -173.73M | -172.92M | -145.99M | -149.44M |
| EPS Basic | -0.56 | -0.60 | -0.63 | -0.55 | -0.59 |
| Normalized Basic EPS | -0.05 | -0.01 | 0.07 | 0.15 | 0.24 |
| EPS Diluted | -0.56 | -0.60 | -0.63 | -0.55 | -0.59 |
| Normalized Diluted EPS | -0.05 | -0.01 | 0.07 | 0.15 | 0.24 |
| Average Basic Shares Outstanding | 514.09M | 459.27M | 391.24M | 325.19M | 260.61M |
| Average Diluted Shares Outstanding | 514.09M | 459.27M | 391.24M | 325.19M | 260.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |